Stem Cell Therapeutics for Oncology: Technologies and Global Markets

Report Code: BIO075A

Publish Date: Mar 2011

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global stem cell anticancer therapeutics market was valued at $859 million in 2010. This market is expected to increase at an 11.3% compound annual growth rate (CAGR) to reach nearly $1.5 billion in 2015.

Report Scope

This study examines the human applications both marketed and in development of anti–cancer and tissue protective therapies and stem cell therapies for oncology conditions. BCC extensively analyzes each market segment, presents its current market status and presents various forecasts for growth over the next 5 years. Other factors such as Food and Drug Administration (FDA) restrictions, government legislation, a cancer’s drug resistance to therapeutics, and/or natural and alternative remedies are also highlighted, where they meet the criteria of what this report is defining as a stem cell based therapeutic. Our financial and sales analysis focuses on the available figures from 2007 through 2009 with estimates for the years 2010 through 2015, including compound annual growth rates (CAGRs). 

Analyst Credentials

Michael Delander is a biotechnology research consultant with more than 15 years of research experience. Michael has been consulting with venture capital based start–ups and larger industry alike since 2003, and has focused on in–depth research in a wide range of medical therapeutics in early development. His key published work is located in national and international organizations including the National Library of Medicine, the University of California as well as numerous Ivy–league libraries.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Stem Cell Therapeutics for Oncology: Technologies and Global Markets122Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW16Free
Chapter- 4: TYPES OF APPLICATIONS: AUTOLOGOUS, ALLOGENEIC, HEALTHY STEM CELL PROMOTER, TUMOR STEM CELL INHIBITOR39Free
Chapter- 5: STEM CELL–BASED THERAPIES IN HUMAN ONCOLOGY SETTINGS 13Free
Chapter- 6: TRADITIONAL MEDICINES 4Free
Chapter- 7: GOVERNMENT REGULATORY AGENCIES AND PROFESSIONAL ASSOCIATIONS10Free
Chapter- 8: MAJOR ONCOLYTIC STEM CELL MANUFACTURERS9Free
Chapter- 9: ONCOLYTIC STEM CELL THERAPUTICS INDUSTRY4Free
Chapter- 10: PATENT ANALYSIS20Free
Chapter- 11: APPENDIX1Free

Related Reports

Recent Reports

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO139B

The global market for single nucleotide polymorphism (SNP) is expected to grow from $32.0 billion in 2024 and is projected to reach $85.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% during the forecast period of 2024 to 2029.

In Vitro Diagnostics (IVD) Quality Controls: Global Market

Published - Jul 2024 | Publisher - Partha Sarathi Das | Code - BIO233B

The global market for in vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 and is projected to reach $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

RNAi Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO127C

The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.

Metabolomics: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO055E

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Hydrogen Storage: Materials, Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - EGY146C

The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Solid State Batteries: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - FCB053B

The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Stem Cell Therapeutics for Oncology: Technologies and Global Markets
Customize Report